Skip to content

Author

Zhi-Ai Xu

We have 5 of 162 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Engineered T cell-agonist chimera for logic-gated STING activation and augmented cancer immunotherapy.

The efficacy of adoptive T cell therapy against solid tumors is markedly hindered by the immunosuppressive microenvironment. Here, we demonstrate that stimulator of interferon genes (STING) activation in tumor-associated macrophages (TAM) enhances the intratumoral infiltration and cytotoxicity of adoptive T cells. We n...

Fang-Min Chen, Meng-Fang Li, Si-Yuan Ren et al. · 0 citations
Review Open access Oct 2026

Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy

Cellular senescence, a stable state of cell cycle arrest triggered by intrinsic and extrinsic stressors, has emerged as a pivotal regulator of tumor immunity and therapeutic resistance. Senescent cells exhibit pronounced temporal heterogeneity in immune modulation. Early-stage senescence enhances antitumor immunity by...

Si-Yu Chen, Jing Su, Ao-Jia Jin et al. · 0 citations
Sep 2026

The Delivery Strategies for PROTAC.

This chapter systematically examines three progressive tiers of PROTAC delivery using stimuli-activatable moieties, and highlights how these strategies achieve spatiotemporally controlled, tumor-selective protein degradation while minimizing off-tumor toxicity.

Yi-Jing Dang, Ze-Li Long, Jing Gao et al. · 0 citations
Review Open access Sep 2026

Molecular design and delivery of extracellular and membrane protein degradation chimeras.

This Review provides a framework for selecting disease-matched degradation routes and advancing meTPDs from platform-specific demonstrations towards predictable therapeutic modalities by integrating molecular design, receptor biology, intracellular trafficking, delivery and pharmacodynamic considerations.

Shu-Tong Lin, Hui-Ling Zhou, Jia-Yan Qiu et al. · 0 citations
Review Jul 2026

The design of activatable photosensitizers and applications in precision immunomodulation.

This review systematically elaborates on the molecular design principles of activatable photosensitizers and their recent advances in precise immunomodulation for cancer therapy, and delves into the underlying mechanisms by which activatable photosensitizers synergistically potentiate anti-tumor immune responses.

Mengzhen Wang, Yuan Huang, Fangmin Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.